Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1979;1:347-354

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bagby, S. P.
Right arrow Articles by Mass, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bagby, S. P.
Right arrow Articles by Mass, R. D.

Hypertension, Vol 1, 347-354, Copyright © 1979 by American Heart Association


ARTICLES

Serial renin-angiotensin studies in spontaneously hypertensive and Wistar-Kyoto normotensive rats. Transition from normal- to high-renin status during the established phase of spontaneous hypertension

SP Bagby, WJ McDonald and RD Mass

To characterize the renin-angiotensin system in the Aoki-Okamoto spontaneously hypertensive rat (SHR) more fully, serial measurements of plasma renin activity (PRA), plasma renin concentration (PRC), renin reactivity (as relative index of circulating modifiers of the renin reaction) and renin substrate concentration were made in 6- to 64-week- old SHR and in age-matched Wistar-Kyoto normotensive rats (WKY). In the evolving phase of SHR hypertension (6 and 13 weeks of age), PRA was comparable to WKY control values, whereas mature SHR with established hypertension developed, between 13 and 35 weeks of age, a high-PRA state persisting through 64 weeks of age. In 64-week-old SHR, increased plasma volume (3.54 +/- 0.91 in SHR vs. 3.18 +/- 0.90 ml/100 g body weight in WKY, p less than 0.025), together with increased PRA (24.9 +/- 3.8 in SHR vs. 13.1 2.2 ng AI/ml plasma/hr in WKY, p less than 0.025), suggest that volume decrease cannot explain increased PRA. In 42-week- old SHR, PRA was incompletely suppressed by deoxycorticosterone acetate plus 1% saline orally for 4 days: 4.9 +/- 1.2 in SHR vs. 0.6 +/- 0.8 ng angiotensin I/ml plasma/hr in WKY, p less than 0.001. Modestly increased renin reactivity of plasma was observed in SHR at all ages studied, supporting the ubiquity of increased circulating accelerators (or decreased inhibitors) of the renin reaction in hypertensive states. However, elevated renin reactivity did not account for the transition from normal to high PRA observed in mature SHR, nor did renin substrate concentration, which was consistently lower in SHR than in age-matched WKY. Temporal patterns of, and strain differences in PRA were closely paralleled by variations in PRC but not by other reaction components. Significant elevation of serum creatinine in old SHR support the presence of renal injury. We conclude that PRA and PRC are normal in evolving SHR hypertension and progress to abnormally elevated levels after hypertension is established. We postulate that "high-renin" hypertension may develop as a consequence of the hypertensive state per se, perhaps due to nephrosclerotic vascular disease.


This article has been cited by other articles:


Home page
EndocrinologyHome page
L. Pinilla, J. M. Castellano, M. Romero, M. Tena-Sempere, F. Gaytan, and E. Aguilar
Delayed Puberty in Spontaneously Hypertensive Rats Involves a Primary Ovarian Failure Independent of the Hypothalamic KiSS-1/GPR54/GnRH System
Endocrinology, June 1, 2009; 150(6): 2889 - 2897.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Paliege, A. Parsumathy, D. Mizel, T. Yang, J. Schnermann, and S. Bachmann
Effect of apocynin treatment on renal expression of COX-2, NOS1, and renin in Wistar-Kyoto and spontaneously hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R694 - R700.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Mitani, N. Ishizaka, T. Aizawa, M. Ohno, S.-i. Usui, T. Suzuki, T. Amaki, I. Mori, Y. Nakamura, M. Sato, et al.
In Vivo klotho Gene Transfer Ameliorates Angiotensin II-Induced Renal Damage
Hypertension, April 1, 2002; 39(4): 838 - 843.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Chen, J. Su, K. Wu, W. Hu, D. G. Gardner, and D. Chen
Early captopril treatment prevents hypertrophy-dependent gene expression in hearts of SHR
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1998; 274(6): R1511 - R1517.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. J. Campbell, A.-M. Duncan, A. Kladis, and S. B. Harrap
Angiotensin Peptides in Spontaneously Hypertensive and Normotensive Donryu Rats
Hypertension, May 1, 1995; 25(5): 928 - 934.
[Abstract] [Full Text]